Erratum: Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study (Oncology (Switzerland) (2012) 81 (235-243) DOI:10.1159/000334779);Vasculopathy related to manic/hypomanic symptom burden and first-generation antipsychotics in a sub-sample from the collaborative depression study

Psychotherapy and Psychosomatics

Volumn 81, Issue 4, 2012, Pages 235-243

  Fiedorowicz, Jess G ^b,c   Coryell, William H ^c   Rice, John P ^a   Warren, Lois L ^c   Haynes, William G ^b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Adult; Antipsychotics; Bipolar disorder; Cardiovascular mortality; Major depression; Mania

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMOTRIGINE; LITHIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRIACYLGLYCEROL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID DERIVATIVE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CHRONICITY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; FEMALE; FLOW MEDIATED DILATION; FOLLOW UP; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOMANIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MANIA; METABOLIC REGULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VASODILATATION;

EID: 84860830735     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000348840     Document Type: Erratum

References (53)

1. Katz MM, Klerman GL: Introduction: overview of the clinical studies program. Am J Psychiatry 1979; 136: 49-51.
2. Katz MM, Secunda SK, Hirschfeld RM, Koslow SH: NIMH clinical research branch collaborative program on the psychobiology of depression. Arch Gen Psychiatry 1979; 36: 765-771. (Pubitemid 10102539)
3. Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Mueller TI, Rice JP, Keller MB: Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000; 57: 375-380. (Pubitemid 30202328)
4. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Leon AC, Solomon DA, Coryell W, Maser JD, Keller MB: Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry 2005; 62: 1322-1330. (Pubitemid 41746610)
5. Coryell W, Haley J, Endicott J, Solomon D, Leon AC, Keller M, Turvey C, Maser JD, Mueller T: The prospectively observed course of illness among depressed patients who commit suicide. Acta Psychiatr Scand 2002; 105: 218-223. (Pubitemid 34280695)
6. Fiedorowicz JG, Solomon DA, Endicott J, Leon AC, Li C, Rice JP, Coryell WH: Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009; 71: 598-606.
7. Fiedorowicz JG, He J, Merikangas KR: The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res 2011; 70: 145-154.
8. Baune BT, Adrian I, Arolt V, Berger K: Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychother Psychosom 2006; 75: 319-326. (Pubitemid 44200480)
9. Osby U, Brandt L, Correia N, Ekbom A, Sparen P: Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844-850. (Pubitemid 32979302)
10. Ormel J, de Jonge P: Unipolar depression and the progression of coronary artery disease: toward an integrative model. Psychother Psychosom 2011; 80: 264-274.
11. Zuidersma M, Thombs BD, de Jonge P: Onset and recurrence of depression as predictors of cardiovascular prognosis in depressed acute coronary syndrome patients: a systematic review. Psychother Psychosom 2011; 80: 227-237.
12. Barth J, Schumacher M, Herrmann-Lingen C: Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66: 802-813. (Pubitemid 39552862)
13. Rybakowski JK, Wykretowicz A, Heymann-Szlachcinska A, Wysocki H: Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry 2006; 60: 889-891. (Pubitemid 44527889)
14. Broadley AJ, Korszun A, Jones CJ, Frenneaux MP: Arterial endothelial function is impaired in treated depression. Heart 2002; 88: 521-523.
15. Lavoie KL, Pelletier R, Arsenault A, Dupuis J, Bacon SL: Association between clinical depression and endothelial function measured by forearm hyperemic reactivity. Psychosom Med 2010; 72: 20-26.
16. Rajagopalan S, Brook R, Rubenfire M, Pitt E, Young E, Pitt B: Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol 2001; 88: 196-198. (Pubitemid 32607714)
17. Pizzi C, Manzoli L, Mancini S, Costa GM: Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J 2008; 29: 1110-1117. (Pubitemid 351844893)
18. Paranthaman R, Greenstein AS, Burns AS, Cruickshank JK, Heagerty AM, Jackson A, Malik RA, Scott ML, Baldwin RC: Vascular function in older adults with depressive disorder. Biol Psychiatry 2010; 68: 133-139.
19. Broadley AJ, Korszun A, Abdelaal E, Moskvina V, Deanfield J, Jones CJ, Frenneaux MP: Metyrapone improves endothelial dysfunction in patients with treated depression. J Am Coll Cardiol 2006; 48: 170-175. (Pubitemid 44202475)
20. Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG: Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002; 105: 1049-1053. (Pubitemid 34212612)
21. Coryell W, Turvey C, Leon A, Maser JD, Solomon D, Endicott J, Mueller T, Keller M: Persistence of depressive symptoms and cardiovascular death among patients with affective disorder. Psychosom Med 1999; 61: 755-761.
22. Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG: Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatry Rep 2009; 11: 475-480.
23. Weiner M, Warren L, Fiedorowicz JG: Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2011; 23: 40-47.
24. Ray WA, Chung CP, Murray KT, Hall K, Stein CM: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360: 225-235.
25. Jeste DV, Blazer D, Casey D, Meeks T, Salzman C, Schneider L, Tariot P, Yaffe K: ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2008; 33: 957-970. (Pubitemid 351367549)
26. Haynes WG: Triglyceride-rich lipoproteins and vascular function. Arterioscler Thromb Vasc Biol 2003; 23: 153-155.
27. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP: Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
28. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
29. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T: Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678. (Pubitemid 33108132)
30. Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, Boden-Albala B, Sacco R, Homma S: The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007; 192: 197-203. (Pubitemid 46602298)
31. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM: Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502-509.
32. Endicott J, Spitzer RL: A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-844. (Pubitemid 9076798)
33. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44: 540-548. (Pubitemid 17082095)
34. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB: A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269. (Pubitemid 36307437)
35. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537. (Pubitemid 34602935)
36. Spitzer RL, Endicott J, Robins E: Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35: 773-782. (Pubitemid 9064061)
37. Fiedorowicz JG, Leon AC, Keller MB, Solomon DA, Rice JP, Coryell WH: Do risk factors for suicidal behavior differ by affective disorder polarity? Psychol Med 2009; 39: 763-771.
38. Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Keller MB, Coryell WH: Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry 2011; 168: 40-48.
39. Coryell W, Fiedorowicz J, Solomon D, Endicott J: Age transitions in the course of bipolar I disorder. Psychol Med 2009; 39: 1247-1252.
40. Coryell W, Solomon D, Leon A, Fiedorowicz JG, Schettler P, Judd L, Keller M: Does major depressive disorder change with age? Psychol Med 2009; 39: 1689-1695.
41. Guthikonda S, Sinkey CA, Haynes WG: What is the most appropriate methodology for detection of conduit artery endothelial dysfunction? Arterioscler Thromb Vasc Biol 2007; 27: 1172-1176. (Pubitemid 46641975)
42. Ghiadoni L, Versari D, Giannarelli C, Faita F, Taddei S: Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 2008; 14: 3715-3722.
43. O'Rourke MF, Pauca AL: Augmentation of the aortic and central arterial pressure waveform. Blood Press Monit 2004; 9: 179-185. (Pubitemid 39159160)
44. Sarafidis PA, Lasaridis AN, Nilsson PM, Pikilidou MI, Stafilas PC, Kanaki A, Kazakos K, Yovos J, Bakris GL: Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. J Hum Hypertens 2007; 21: 709-716. (Pubitemid 47335301)
45. Verhaeverbeke I, Mets T: Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Saf 1997; 17: 105-118. (Pubitemid 27395575)
46. Gepdiremen A, Aydin N, Halici Z, Sahin O, Unal B, Aydin MD, Bakuridze K: Chronic treatment of haloperidol causes vasoconstriction on basilar arteries of rats, dose dependently. Pharmacol Res 2004; 50: 569-574. (Pubitemid 39402976)
47. Mannelli M, Lazzeri C, Ianni L, La Villa G, Pupilli C, Bellini F, Serio M, Franchi F: Dopamine and sympathoadrenal activity in man. Clin Exp Hypertens 1997; 19: 163-179. (Pubitemid 27084534)
48. McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A, Gallacher J, Ben-Shlomo Y, Cockcroft JR, Wilkinson IB: An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension 2010; 56: 36-43.
49. Hoen PW, Conradi HJ, Denollet J, Martens EJ, de Jonge P: Interview-based ratings of somatic and cognitive symptoms of depression and their impact on cardiovascular prognosis. Psychother Psychosom 2010; 79: 319-320.
50. Lemogne C, Nabi H, Zins M, Cordier S, Ducimetiere P, Goldberg M, Consoli SM: Hostility may explain the association between depressive mood and mortality: evidence from the French GAZEL cohort study. Psychother Psychosom 2010; 79: 164-171.
51. Benninghoven D, Kaduk A, Wiegand U, Specht T, Kunzendorf S, Jantschek G: Influence of anxiety on the course of heart disease after acute myocardial infarction - risk factor or protective function? Psychother Psychosom 2006; 75: 56-61. (Pubitemid 41816065)
52. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE: Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom 2004; 73: 344-352. (Pubitemid 39370523)
53. Wang HX, Mittleman MA, Leineweber C, Orth-Gomer K: Depressive symptoms, social isolation, and progression of coronary artery atherosclerosis: the Stockholm Female Coronary Angiography Study. Psychother Psychosom 2006; 75: 96-102.